These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 35483929)
1. Human acute myeloid leukemia stem cells: evolution of concept. Shin DY Blood Res; 2022 Apr; 57(S1):67-74. PubMed ID: 35483929 [TBL] [Abstract][Full Text] [Related]
2. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A; Gillis D; Lewis I J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508 [TBL] [Abstract][Full Text] [Related]
3. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities. Marchand T; Pinho S Front Immunol; 2021; 12():775128. PubMed ID: 34721441 [TBL] [Abstract][Full Text] [Related]
4. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML. Herrmann H; Sadovnik I; Eisenwort G; Rülicke T; Blatt K; Herndlhofer S; Willmann M; Stefanzl G; Baumgartner S; Greiner G; Schulenburg A; Mueller N; Rabitsch W; Bilban M; Hoermann G; Streubel B; Vallera DA; Sperr WR; Valent P Blood Adv; 2020 Oct; 4(20):5118-5132. PubMed ID: 33085758 [TBL] [Abstract][Full Text] [Related]
5. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia. de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595 [TBL] [Abstract][Full Text] [Related]
6. CD93 Marks a Non-Quiescent Human Leukemia Stem Cell Population and Is Required for Development of MLL-Rearranged Acute Myeloid Leukemia. Iwasaki M; Liedtke M; Gentles AJ; Cleary ML Cell Stem Cell; 2015 Oct; 17(4):412-21. PubMed ID: 26387756 [TBL] [Abstract][Full Text] [Related]
7. Hematopoietic versus leukemic stem cell quiescence: Challenges and therapeutic opportunities. O'Reilly E; Zeinabad HA; Szegezdi E Blood Rev; 2021 Nov; 50():100850. PubMed ID: 34049731 [TBL] [Abstract][Full Text] [Related]
8. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells. Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383 [TBL] [Abstract][Full Text] [Related]
9. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia. Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948 [TBL] [Abstract][Full Text] [Related]
10. Murine models based on acute myeloid leukemia-initiating stem cells xenografting. Mambet C; Chivu-Economescu M; Matei L; Necula LG; Dragu DL; Bleotu C; Diaconu CC World J Stem Cells; 2018 Jun; 10(6):57-65. PubMed ID: 29988882 [TBL] [Abstract][Full Text] [Related]
11. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance. Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687 [TBL] [Abstract][Full Text] [Related]
12. Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapy. Kikushige Y Blood Cell Ther; 2022 Dec; 5(Spec Edition):S1-S5. PubMed ID: 37220607 [TBL] [Abstract][Full Text] [Related]
13. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Jin L; Hope KJ; Zhai Q; Smadja-Joffe F; Dick JE Nat Med; 2006 Oct; 12(10):1167-74. PubMed ID: 16998484 [TBL] [Abstract][Full Text] [Related]
14. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells. Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991 [TBL] [Abstract][Full Text] [Related]
15. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms. Tan M; Zhang Q; Yuan X; Chen Y; Wu Y J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595 [TBL] [Abstract][Full Text] [Related]
17. The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: From biology to therapeutic targeting. Chen Y; Li J; Xu L; Găman MA; Zou Z Cell Death Discov; 2022 Sep; 8(1):397. PubMed ID: 36163119 [TBL] [Abstract][Full Text] [Related]
18. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505 [TBL] [Abstract][Full Text] [Related]
19. [Acute myeloid leukemia stem cells from genomic and immunological perspectives]. Goyama S Rinsho Ketsueki; 2020; 61(9):1130-1137. PubMed ID: 33162508 [TBL] [Abstract][Full Text] [Related]
20. Leukemia Stem Cells in the Pathogenesis, Progression, and Treatment of Acute Myeloid Leukemia. Joshi K; Zhang L; Breslin S J P; Zhang J Adv Exp Med Biol; 2019; 1143():95-128. PubMed ID: 31338817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]